companydata.dkNORDIC BIOTECH PRIVATE INVESTORS ApS: Financial statements 2021
CVR: 26284384
NORDIC BIOTECH PRIVATE INVESTORS ApS (CVR 26284384) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -15,250 and a net result of DKK -167,628 compared with DKK -54,970 the year before. Equity amounted to DKK 2,511,295. The solvency ratio was 99.5%.
- Gross Profit
- -15,250 kr.
- Profit/Loss
- -167,628 kr.
- Equity
- 2,511,295 kr.
- Total Assets
- 2,522,670 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -15 t. | -168 t. | 2.5 mio. | 0 |
| 2020 | - | -16 t. | -55 t. | 2.7 mio. | - |
| 2019 | - | -29 t. | 262 t. | 2.7 mio. | - |
| 2018 | - | -24 t. | -10.6 mio. | 2.5 mio. | 0 |
| 2017 | - | 47.5 mio. | 2.9 mio. | 13.1 mio. | - |
Find more companies like NORDIC BIOTECH PRIVATE INVESTORS ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
NORDIC BIOTECH PRIVATE INVESTORS ApS has published its annual report for 2020. Gross profit came to DKK -15,938, and the net result was DKK -54,970.
About NORDIC BIOTECH PRIVATE INVESTORS ApS
NORDIC BIOTECH PRIVATE INVESTORS ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2001. The company was registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jakob Mosegaard Larsen. The company's owners include Thue Walter Schwartz, Peter Moldt and Dorte Kloppenborg Skrumsager. In 2025, the company reported a gross profit of DKK -432,293 and a net result of DKK -571,396 compared with DKK 2,080,087 the year before. Equity amounted to DKK 2,975,449.